Mutasynthesis and Antibiotic Activity of Mupirocin Analogues

Sarah M Husain1,2, Luoyi Wang1,3, Li-Chen Han1

  • 1School of Chemistry, Cantock's Close, University of Bristol, Bristol, UK.

Insights

Mutasynthesis enabled the creation of novel pseudomonic acid (PA) analogues with retained antibiotic activity. One analogue, lacking unstable features, shows promise for developing new antibacterial agents against resistant bacteria.

Area of Science:

  • Natural Product Biosynthesis
  • Synthetic Biology
  • Medicinal Chemistry

Background:

  • Mupirocin, a mixture of pseudomonic acids (PAs), possesses antibiotic properties against Gram-positive bacteria, including MRSA.
  • Understanding complex biosynthetic pathways is crucial for developing novel antimicrobial compounds.
  • Mutasynthesis, combining metabolic engineering and chemical synthesis, offers a powerful strategy for generating compound diversity.

Purpose of the Study:

  • To develop a flexible mutasynthesis approach for creating novel pseudomonic acid analogues.
  • To evaluate the antimicrobial activities of these synthetic analogues.
  • To investigate the structure-activity relationships of PAs.

Main Methods:

  • Utilized mutasynthesis to generate a library of novel PA analogues.
  • Assessed antimicrobial activity against Bacillus subtilis and four Staphylococcus aureus strains.
  • Synthesized a C7 analogue of a key biosynthetic intermediate (desepoxy-PA-B) and conducted feeding studies.

Main Results:

  • One novel PA analogue retained significant antimicrobial activity while lacking the 10,11-epoxide and ester linkage found in PA-A.
  • This analogue demonstrated stability by replacing the epoxide with an alkene and the ester with a ketone.
  • Feeding studies confirmed the conversion of C7-desepoxy-PA-B to a novel metabolite, C7-PA-C, with modifications at the 8-hydroxyl group and side chain.

Conclusions:

  • Mutasynthesis is an effective strategy for producing stable and active pseudomonic acid analogues.
  • The developed analogues show potential as new antibacterial agents, particularly against resistant strains.
  • Further research into these stable analogues could lead to the development of improved antibiotics.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...